Niraparib as maintenance therapy in Japan: a retrospective observational study using a Japanese claims database.

Takashi Motohashi Muneaki Shimada Hideki Tokunaga Yuki Kuwahara Hiroyo Kuwabara Ai Kato Tsutomu Tabata

Published in: Journal of gynecologic oncology (2024)

Niraparib demonstrated favorable tolerability in Japanese patients with advanced EOC, with effective management of thrombocytopenia through dose adjustments and supportive care, supporting its viability as post-chemotherapy maintenance therapy.

Keyphrases

healthcare
palliative care
quality improvement
health insurance
squamous cell carcinoma
stem cells
open label
clinical trial
emergency department
pain management
mesenchymal stem cells
bone marrow
study protocol
rectal cancer